Acambis’ Smallpox Vaccine Could See Approval As Soon As First Half 2007
An FDA “complete response” letter for the cell-based vaccine cites both clinical and CMC sections of the BLA, firm tells “The Pink Sheet” DAILY.
An FDA “complete response” letter for the cell-based vaccine cites both clinical and CMC sections of the BLA, firm tells “The Pink Sheet” DAILY.